カテゴリ： MarketLine, アメリカ, 企業調査

CVS Health Corporation：企業の戦略・SWOT・財務情報

◆英語タイトル：CVS Health Corporation - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C1925
◆発行会社（調査会社）：MarketLine
◆発行日：2018年7月
◆ページ数：62
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

CVS Health Corporation – Strategy, SWOT and Corporate Finance Report
Summary

CVS Health Corporation – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

CVS Health Corporation (CVS or ‘the company’), formerly known as CVS Caremark Corporation, together with its subsidiaries, is the largest integrated pharmacy health care provider in the US. The company also operates its retail/LTC business in Puerto Rico and Brazil. CVS is headquartered in Woonsocket, Rhode Island.

Scope

- Detailed information on CVS Health Corporation required for business and competitor intelligence needs
- A study of the major internal and external factors affecting CVS Health Corporation in the form of a SWOT analysis
- An in-depth view of the business model of CVS Health Corporation including a breakdown and examination of key business segments
- Intelligence on CVS Health Corporation’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about CVS Health Corporation, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of CVS Health Corporation and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess CVS Health Corporation as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on CVS Health Corporation’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
CVS Health Corporation: Company Overview 9
CVS Health Corporation: Overview and Key Facts 9
CVS Health Corporation: Overview 9
CVS Health Corporation: Key Facts 9
CVS Health Corporation: Key Employees 10
CVS Health Corporation: Key Employee Biographies 13
CVS Health Corporation: Major Products and Services 20
CVS Health Corporation: Company History 21
CVS Health Corporation: Management Statement 28
CVS Health Corporation: Locations and Subsidiaries 34
CVS Health Corporation: Key Competitors 35
CVS Health Corporation: Company Analysis 36
CVS Health Corporation: Business Description 36
CVS Health Corporation: SWOT Analysis 38
CVS Health Corporation: SWOT Overview 38
CVS Health Corporation: Strengths 38
CVS Health Corporation: Weaknesses 40
CVS Health Corporation: Opportunities 41
CVS Health Corporation: Threats 42
CVS Health Corporation: Corporate Financial Deals Activity 43
CVS Health Corporation: Financial Deals Overview 43
CVS Health Corporation: Targets and Partners 45
CVS Health Corporation: Top Deals 2014 – 2018YTD* 46
CVS Health Corporation: Advisors 47
CVS Health Corporation: Top Legal Advisors 47
CVS Health Corporation: Top Financial Advisors 47
CVS Health Corporation: Mergers and Acquisitions 49
CVS Health Corporation: Corporate Venturing 50
CVS Health Corporation: Capital Raising 51
CVS Health Corporation: Recent Developments 52
CVS Health Corporation: News and Events Summary 52
CVS Health Corporation: Contracts 55
CVS Health Corporation: Corporate Governance 56
CVS Health Corporation: Corporate Social Responsibility 57
CVS Health Corporation: Financial Deals 57
CVS Health Corporation: Strategy and Operations 58
Appendix 60
Contact Us 60
Methodology 60
About MarketLine 61

List of Tables
Table 1: CVS Health Corporation: Key Facts
Table 2: CVS Health Corporation: Key Employees
Table 3: CVS Health Corporation: Locations and Subsidiaries
Table 4: CVS Health Corporation: Key Competitors
Table 5: CVS Health Corporation: Deal Activity by Deal Type - Volume (TTM*)
Table 6: CVS Health Corporation: M&A Activity by Geography (TTM*)
Table 7: CVS Health Corporation: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: CVS Health Corporation: M&A Average Deal Size - Value (US$m)
Table 9: CVS Health Corporation: Targets and Partners
Table 10: CVS Health Corporation: Top Deals 2014 - 2018YTD*
Table 11: CVS Health Corporation: Legal Advisor Ranking by Value (US$m)
Table 12: CVS Health Corporation: Financial Advisor Ranking by Value (US$m)
Table 13: CVS Health Corporation: M&A Volume and Value Trend (2014 - YTD*2018)
Table 14: CVS Health Corporation: M&A Activity by Geography (2014 - YTD*2018)
Table 15: CVS Health Corporation: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 16: CVS Health Corporation: Corporate Venturing by Geography (2014 - YTD*2018)
Table 17: CVS Health Corporation: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 18: CVS Health Corporation: Capital Raising by Deal Type (2014 - YTD*2018)
Table 19: CVS Health Corporation: News and Events Summary
Table 20: CVS Health Corporation: Contracts
Table 21: CVS Health Corporation: Corporate Governance
Table 22: CVS Health Corporation: Corporate Social Responsibility
Table 23: CVS Health Corporation: Financial Deals
Table 24: CVS Health Corporation: Strategy and Operations

List of Figures
Figure 1: CVS Health Corporation: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: CVS Health Corporation: M&A Activity by Geography (TTM*)
Figure 3: CVS Health Corporation: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: CVS Health Corporation: M&A Average Deal Size - Value (US$m)
Figure 5: CVS Health Corporation: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: CVS Health Corporation: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: CVS Health Corporation: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 8: CVS Health Corporation: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 9: CVS Health Corporation: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 10: CVS Health Corporation: Capital Raising by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[CVS Health Corporation：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Align Technology, Inc. (ALGN)-医療機器分野：企業M&A・提携分析
    Summary Align Technology, Inc. (Align) is a medical device company that designs, manufactures and markets orthodontics and services for orthodontic and restorative dentistry. The company’s portfolio encompasses a system of clear aligner therapy, intra-oral scanners, and computer-aided design, and co …
  • Mitsubishi Heavy Industries, Ltd.：企業の戦略・SWOT・財務分析
    Mitsubishi Heavy Industries, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi Heavy Industries, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Electromagnetic Geoservices ASA (EMGS)：企業の財務・戦略的SWOT分析
    Summary Electromagnetic Geoservices ASA (EMGS) is an oil and gas service provider that explores workflow working with seismic, petrophysical and geologic data. The company gathers controlled source electromagnetic data and conduct modeling, integration, interpretation. Its technology finds applicati …
  • ABIONYX Pharma SA (CEREN)：企業の財務・戦略的SWOT分析
    Summary ABIONYX Pharma SA (ABIONYX) is a biopharmaceutical company that discovers and develops HDL therapies for the treatment of cardiovascular and metabolic diseases. Its therapies include CER-001 a negatively-charged lipoprotein particle that find application in atheosclerotic plaque regression; …
  • XBiotech Inc (XBIT)：製薬・医療：M&Aディール及び事業提携情報
    Summary XBiotech Inc (XBiotech) is a biopharmaceutical company that discovers, develops and commercialize therapeutic antibodies based proprietary technology. The company provides monoclonal antibodies treatment for various diseases. It’s lead product Xilonix, a therapeutic antibody being developed …
  • Gibson Energy Inc (GEI)：企業の財務・戦略的SWOT分析
    Gibson Energy Inc (GEI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • The E. W. Scripps Company (SSP)：企業の財務・戦略的SWOT分析
    The E. W. Scripps Company (SSP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Wirecard AG：企業の戦略・SWOT・財務分析
    Wirecard AG - Strategy, SWOT and Corporate Finance Report Summary Wirecard AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Adverum Biotechnologies Inc (ADVM)：製薬・医療：M&Aディール及び事業提携情報
    Summary Adverum Biotechnologies Inc (Adverum), formerly Avalanche Biotechnologies Inc, is a clinical-stage gene therapy provider. The company’s product pipeline includes AVDM-053, ADVM-022 and AVA-311. Its products are used for treatment of antitrypsin deficiency, hereditary angioedema, wet age-rela …
  • LG Electronics, Inc.：戦略・SWOT・企業財務分析
    LG Electronics, Inc. - Strategy, SWOT and Corporate Finance Report Summary LG Electronics, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Romelectro S.A.：企業の戦略的SWOT分析
    Romelectro S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Fluidigm Corp (FLDM)：企業の財務・戦略的SWOT分析
    Summary Fluidigm Corp (Fluidigm), formerly Mycometrix Corp, develops, manufactures, and markets life science analytical and preparatory systems for mass cytometry, high-throughput genomics, and single-cell genomics markets. The company offers analytical systems and instruments, preparatory instrumen …
  • KDDI Corporation：戦略・SWOT・企業財務分析
    KDDI Corporation - Strategy, SWOT and Corporate Finance Report Summary KDDI Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Toray Industries Inc (3402)：電力：M&Aディール及び事業提携情報
    Summary Toray Industries Inc (Toray) is a provider of advanced materials. The company's product portfolio includes fibers, fashion apparel, plastics, chemicals, IT-related products, composite materials, life sciences products, and medical devices, pharmaceuticals, and optical products. It provides i …
  • Navitor Pharmaceuticals Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Navitor Pharmaceuticals Inc (Navitor Pharmaceuticals) is a biopharmaceutical company that develops medicines by targeting cellular nutrient signaling pathways. The company harnesses its proprietary drug discovery platform to develop selective modulators of the mTORC1 pathway. It develops mTO …
  • Public Gas Corporation SA：企業の戦略的SWOT分析
    Public Gas Corporation SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • IDFC Ltd (IDFC)：企業の財務・戦略的SWOT分析
    IDFC Ltd (IDFC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • EMCOR Group, Inc.：企業の戦略・SWOT・財務情報
    EMCOR Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary EMCOR Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • 3W Power SA：企業の戦略的SWOT分析
    3W Power SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Constellation Brands Inc (STZ)：企業の財務・戦略的SWOT分析
    Constellation Brands Inc (STZ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆